Unimolecular Guide Molecule Synthesis via Fragment Annealing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for synthesizing guide molecules for CRISPR systems are costly and inefficient, particularly for commercial-scale production, and often result in contamination with n-1 and n+1 species due to limitations in chemical synthesis techniques.

Innovation Solution

A method involving pre-annealing of guide fragments followed by cross-linking using reactive groups, such as amine-functionalized fragments with urea-based cross-linking, to form unimolecular guide molecules with improved sequence fidelity and reduced contamination.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If chemical synthesis methods are used to produce guide molecules, then manufacturing cost is reduced and production is simplified, but the guide molecules are contaminated with n-1 and n+1 species

Engineering Contradiction:
Improvemanufacturing cost and production simplicityVSAvoidsequence fidelity and contamination levels
Core Design Contradiction:
Ease of manufactureVSManufacturing precision

Solution Approach 1:

The guide molecule is divided into multiple separate oligonucleotide fragments that are synthesized individually through chemical synthesis, then assembled together through annealing and crosslinking. This segmentation allows each fragment to be synthesized with high purity while avoiding the accumulation of n-1 and n+1 species that would occur in full-length chemical synthesis

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The oligonucleotide fragments are pre-annealed to form duplexes before the final crosslinking step. This preliminary annealing ensures proper base pairing and structural formation, allowing the fragments to be joined in the correct orientation and reducing misassembly errors

Inventive Principle:
Principle #10Preliminary action

2Manufacturing precision

If in-vitro transcription is used to synthesize guide molecules, then full-length sequences are obtained, but manufacturing is costly and limited in scale

Engineering Contradiction:
Improvefull-length sequence accuracyVSAvoidmanufacturing cost and scalability
Core Design Contradiction:
Manufacturing precisionVSEase of manufacture

Solution Approach 1:

Instead of transcribing the entire guide molecule sequence in a single in-vitro transcription reaction, the method segments the sequence into multiple shorter oligonucleotide fragments that can be chemically synthesized. These fragments are then assembled to reconstruct the full-length guide molecule, achieving both the scalability of chemical synthesis and the full-length accuracy of in-vitro transcription

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The oligonucleotide fragments serve as intermediaries between the chemical synthesis process and the final guide molecule product. These fragments are chemically synthesized with high purity, then used as building blocks that are annealed and crosslinked to form the complete guide molecule, bridging the gap between synthesis method and final product quality

Inventive Principle:
Principle #24Intermediary (Mediator)

3Productivity

If T7 polymerase is used for in-vitro transcription, then RNA synthesis occurs, but sequences starting with 5' guanine are transcribed more efficiently than other bases

Engineering Contradiction:
Improvetranscription efficiencyVSAvoidsequence representation accuracy
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The method extracts the problematic 5' end sequence from the transcription process by using chemical synthesis to create oligonucleotide fragments with the desired 5' sequences. This avoids the T7 polymerase bias toward guanine-starting sequences, as the fragments are synthesized chemically with precise control over their 5' ends, then assembled into the complete guide molecule

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The approach results in high-purity, full-length unimolecular guide molecules with minimal n-1 and n+1 species, enhancing their effectiveness and specificity in genome editing applications.

Implementation Method 1

annealing a first oligonucleotide and a second oligonucleotide to form a duplex between a 3' region of the first oligonucleotide and a 5' region of the second oligonucleotide

Methodology Applied
Scientific EffectAnnealing: Annealing

Implementation Method 2

conjugating the annealed first and second oligonucleotides via the first and second reactive groups to form a unimolecular guide RNA molecule that includes a covalent bond linking the first and second oligonucleotides

Methodology Applied
Scientific EffectChemical Bonding: Chemical Bonding

Data Source

PatentUS20230111575A1Synthetic guide molecules, compositions and methods relating thereto
Publication Date: 2023.04.13 EDITAS MEDICINE INC
  • US20230111575A1 patent drawing
  • US20230111575A1 patent drawing
  • US20230111575A1 patent drawing

AI summary

Chemical syntheses of guide molecules are disclosed, along with compositions and methods relating thereto.